As a leading USA-based peptide synthesis facility, PX1 Research manufactures high-purity Chonluten (Glu-Asp-Gly) for laboratory investigation into cellular redox homeostasis and pulmonary tissue signaling. Our ISO 17025-accredited testing procedures ensure rigorous lot-to-lot consistency, full analytical transparency, and ultralow endotoxin thresholds for demanding in vitro and preclinical research applications.
As a leading USA-based peptide synthesis facility, PX1 Research manufactures high-purity Chonluten (Glu-Asp-Gly) for laboratory investigation into cellular redox homeostasis and pulmonary tissue signaling. Our ISO 17025-accredited testing procedures ensure rigorous lot-to-lot consistency, full analytical transparency, and ultralow endotoxin thresholds for demanding in vitro and preclinical research applications.
A professional manufacturer of Chonluten for antioxidant enzyme regulation provides research-grade tripeptide (L-glutamyl-L-aspartyl-glycine) synthesized via solid-phase methods under strict quality controls. Preclinical data show Chonluten interacts with chromatin and gene promoters to modulate endogenous antioxidant enzymes like superoxide dismutase (SOD) and catalase in bronchial tissue, requiring RP-HPLC and mass spectrometry verification for experimental reproducibility.
In laboratory settings, investigating the precise pathways through which short bioregulatory peptides influence cellular stress responses demands chemical purity beyond commercial grade. Research teams evaluating antioxidant enzyme regulation Chonluten require absolute structural verification and batch stability. PX1 Research delivers laboratory-grade peptides manufactured strictly for in vitro assays and animal models, ensuring that background contamination or peptide degradation does not skew gene expression data.
Chonluten is a synthetic tripeptide consisting of the amino acid sequence L-glutamyl-L-aspartyl-glycine (H-Glu-Asp-Gly-OH, commonly abbreviated as EDG). Categorized within the broad family of Khavinson peptide bioregulators, its low molecular weight allows it to engage directly with intracellular and nuclear components without requiring specialized transport proteins.
Chemical analysis indicates that the acidic side chains of glutamic and aspartic acid within the sequence provide specific charge distributions capable of electrostatic interaction with histone proteins and double-stranded DNA. Researchers utilizing research peptides targeting epigenetic regulation frequently select Chonluten to assess direct transcriptional activation, specifically looking at how short oligopeptides bind within the major and minor grooves of specific promoter regions.
Cellular oxidative stress occurs when reactive oxygen species (ROS) overwhelm baseline scavenging systems. Preclinical studies suggest that Chonluten acts as a transcriptional modulator rather than a direct chemical antioxidant or ROS scavenger. Instead of donating electrons directly to neutralize free radicals, in vitro assays indicate that EDG application leads to upregulated expression of primary endogenous enzymatic defenses.
Specifically, quantitative PCR and Western blot analyses in cultured pulmonary epithelial cells demonstrate increased mRNA transcription for superoxide dismutase (SOD1/SOD2), catalase (CAT), and glutathione peroxidase (GPx). By enhancing the intracellular concentration of these primary antioxidant enzymes, Chonluten helps restore physiological redox equilibrium in models exposed to toxic insults, inflammatory cytokines, or hypoxic stress. Laboratory investigators access our research library hub to evaluate full biochemical pathways and literature citations surrounding peptide-driven gene regulation.
The primary focus of Chonluten investigation centers on bronchial and alveolar tissue dynamics. In rodent models of acute lung injury and chronic pulmonary inflammation, administration of high-purity EDG has been shown to reduce lipid peroxidation markers such as malondialdehyde (MDA) while preserving tissue morphology. Preclinical data indicate that this protective effect is mediated by the stabilization of mitochondrial membrane potential and reduced cleavage of apoptotic markers like caspase-3.
Furthermore, co-culture experiments involving human bronchial epithelial cells (BEAS-2B) subjected to cigarette smoke extract or lipopolysaccharide (LPS) challenges demonstrate that Chonluten pretreatment attenuates pro-inflammatory cytokine secretion (TNF-alpha, IL-6, IL-8). The reduction in inflammatory signaling directly correlates with the upregulation of total intracellular antioxidant capacity, illustrating the compound's dual role in redox regulation and tissue homeostasis.
When designing protocols for cellular aging and respiratory tissue stability, researchers frequently compare Chonluten against structurally or functionally related short peptides. Understanding these distinctions is critical for selecting the appropriate compound for specific molecular targets:
While Chonluten (Glu-Asp-Gly) focuses on antioxidant enzyme expression within respiratory epithelia, Bronchogen peptide synthesis (Ala-Glu-Asp-Leu) targets structural repair and mucosal barrier function in similar models. Meanwhile, Epitalon telomerase research (Ala-Glu-Asp-Gly) exhibits broader systemic effects on telomerase expression and neuroendocrine regulation. Comparing these three short peptides allows investigators to map specific amino acid sequence variations to distinct gene activation patterns in stress-response pathways.
Synthesizing short oligopeptides like Chonluten requires meticulous process control to avoid racemization, incomplete coupling, and organic solvent retention. PX1 Research utilizes advanced Solid-Phase Peptide Synthesis (SPPS) methodologies within state-of-the-art, GMP-compliant US facilities to yield precise sequence fidelity.
Because small peptides possess minimal steric hindrance, improper synthesis conditions can lead to side-chain reactions on the aspartic and glutamyl carboxyl groups. Our synthesis protocols utilize optimized protection/deprotection schemes and stringent wash cycles. This ensures that every lot of Chonluten manufactured exhibits uniform solubility, exact molecular mass, and zero cross-contamination, supporting high-throughput screening and rigorous experimental control.
To ensure reliable experimental outcomes, every batch of peptide produced by PX1 Research undergoes rigorous analytical testing at an independent ISO 17025 accredited laboratory. Researchers receive comprehensive documentation validating compound identity, purity, and safety profiles prior to laboratory use:
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Establishes chemical purity, ensuring target peptide concentration meets or exceeds 98.0% with minimal truncated or deletion sequences. 2. Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact monoisotopic mass and structural identity, eliminating ambiguity regarding sequence correctness. 3. Endotoxin Assay (LAL Testing): Measures bacterial lipopolysaccharide contamination. PX1 Research guarantees endotoxin levels below 0.01 EU/mg, preventing unwanted immune activation in delicate cell culture assays. 4. Residual Solvent & Heavy Metal Analysis: Verifies total removal of trifluoroacetic acid (TFA), counterions, and synthesis reagents that could introduce cellular toxicity.
Maintaining structural integrity during storage and preparation is essential for working with synthetic tripeptides. PX1 Research supplies Chonluten as a lyophilized (freeze-dried) powder sealed under inert gas to prevent moisture uptake and oxidative degradation during transit.
Upon arrival, lyophilized vials should be stored at -20°C for short-term projects or -80°C for long-term storage. For reconstitution in laboratory settings, researchers should use sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4). Avoid repeated freeze-thaw cycles by aliquoting reconstituted solutions into single-use microcentrifuge tubes. When working with bulk research procurement, proper storage infrastructure ensures lot stability over extended multi-phase studies.
Acquiring high-purity bioregulatory peptides requires partnering with a transparent, US-based manufacturer capable of providing full lot traceability. PX1 Research supports academic institutions, biotechnology companies, and contract research organizations (CROs) with fully documented research materials.
Every shipment originates from our centralized California or Arizona facilities, featuring same-day dispatch for orders placed before cutoff times (Monday through Friday). By maintaining complete control over synthesis, analytical verification, and fulfillment, PX1 Research eliminates supply chain ambiguity, providing researchers with the consistency required for reproducible, high-impact scientific publications.
What is the sequence and molecular weight of Chonluten?
Chonluten is a synthetic tripeptide composed of L-glutamyl-L-aspartyl-glycine (Glu-Asp-Gly or EDG) with a molecular formula of C11H17N3O8 and a molecular weight of approximately 319.27 g/mol.
How does Chonluten regulate antioxidant enzymes in preclinical models?
Preclinical evidence suggests Chonluten acts epigenetically by interacting with chromatin structures and promoter regions, stimulating gene transcription for endogenous antioxidant enzymes including superoxide dismutase (SOD), catalase, and glutathione peroxidase.
What analytical testing is provided with PX1 Research Chonluten?
Every lot is accompanied by a third-party ISO 17025 Certificate of Analysis (COA) containing RP-HPLC chromatograms verifying >98% purity, ESI-MS spectra confirming molecular mass, and chromogenic LAL test results confirming endotoxin levels under 0.01 EU/mg.
What is the recommended reconstitution solvent for Chonluten in cell culture assays?
Chonluten is highly soluble in aqueous media. For standard in vitro assays, reconstitution in sterile PBS (pH 7.4) or sterile laboratory-grade water is recommended. Aliquot immediately to minimize freeze-thaw cycles.
How should lyophilized Chonluten be stored upon delivery?
Lyophilized vials should be stored at -20°C for storage up to 12 months, or at -80°C for extended stability. Reconstituted aliquots should be stored at -80°C and used promptly upon thawing.
Is Chonluten approved for human therapeutic or medical use?
No. Chonluten supplied by PX1 Research is strictly designated for laboratory research, in vitro assays, and preclinical animal models. It is not intended for human or veterinary medical, clinical, or therapeutic application.
How does Chonluten differ structurally from Bronchogen and Epitalon?
Chonluten is a tripeptide (Glu-Asp-Gly), whereas Bronchogen is a tetrapeptide (Ala-Glu-Asp-Leu) and Epitalon is a tetrapeptide (Ala-Glu-Asp-Gly). While all three belong to the short peptide bioregulator class, sequence variations alter their specific receptor affinity and promoter binding targets.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in US-based, GMP-compliant facilities and shipped directly from our fulfillment centers in California and Arizona with same-day shipping on business days.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.